These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31660843)

  • 1. Evaluation of Tissue and Serum Expression Levels of Lactate Dehydrogenase Isoenzymes in Patients with Head and Neck Squamous Cell Carcinoma.
    Mohtasham N; Ayatollahi H; Saghravanian N; Zare R; Shakeri MT; Sahebkar A; Mohajertehran F
    Anticancer Agents Med Chem; 2019; 19(17):2072-2078. PubMed ID: 31660843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum lactate dehydrogenase and alkaline phosphatase in different histological grades of head and neck squamous cell carcinoma and premalignant lesions.
    Bhattacharjee A; Giri S; Roy M; Chakraborty A
    J Cancer Res Ther; 2018; 14(5):934-940. PubMed ID: 30197328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring a 'metabolic shift' after surgical resection of oral squamous cell carcinomas by serum lactate dehydrogenase.
    Grimm M; Krimmel M; Hoefert S; Kraut W; Calgéer B; Biegner T; Teriete P; Munz A; Reinert S
    J Oral Pathol Med; 2016 May; 45(5):346-55. PubMed ID: 26403591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Lactate Dehydrogenase in the Saliva and Tissues of Patients with Head and Neck Squamous Cell Carcinoma.
    Mohajertehran F; Ayatollahi H; Jafarian AH; Khazaeni K; Soukhtanloo M; Shakeri MT; Mohtasham N
    Rep Biochem Mol Biol; 2019 Jan; 7(2):142-149. PubMed ID: 30805393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.
    Ziebart T; Walenta S; Kunkel M; Reichert TE; Wagner W; Mueller-Klieser W
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):193-9. PubMed ID: 20383719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD100-plexin-B1 induces epithelial-mesenchymal transition of head and neck squamous cell carcinoma and promotes metastasis.
    Zhang C; Qiao H; Guo W; Liu Y; Yang L; Liu Y; Jin B; Fu M; Wang G; Li W
    Cancer Lett; 2019 Jul; 455():1-13. PubMed ID: 30981760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the circadian Period family genes is positively correlated with poor head and neck squamous cell carcinoma prognosis.
    Li YY; Jin F; Zhou JJ; Yu F; Duan XF; He XY; Wang R; Wu WL; Long JH; Luo XL
    Chronobiol Int; 2019 Dec; 36(12):1723-1732. PubMed ID: 31609143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ZCCHC6 expression in peripheral blood mononuclear cells by HNSCC secretions.
    Arayataweegool A; Srisuttee R; Bin-Alee F; Mahattanasakul P; Tangjaturonrasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
    Gene; 2020 Sep; 754():144880. PubMed ID: 32526260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated pretreatment lactate dehydrogenase and albumin-to-alkaline phosphatase ratio predict poor prognosis and early treatment discontinuation in head and neck cancer patients with preexistent diabetes mellitus.
    Mireștean CC; Stan MC; Iancu RI; Iancu DPT; Bădulescu F
    Bratisl Lek Listy; 2024; 125(7):457-462. PubMed ID: 38943508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic Role of ZFAS1 lncRNA in Head and Neck Squamous Cell Carcinomas.
    Kolenda T; Guglas K; Kopczyńska M; Teresiak A; Bliźniak R; Mackiewicz A; Lamperska K; Mackiewicz J
    Cells; 2019 Apr; 8(4):. PubMed ID: 31010087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.
    Chen Y; Maniakas A; Tan L; Cui M; Le X; Niedzielski JS; Michel KA; Harlan CJ; Lu W; Henderson YC; Mohamed ASR; Lorenzi PL; Putluri N; Bankson JA; Sandulache VC; Lai SY
    Br J Cancer; 2021 May; 124(10):1670-1679. PubMed ID: 33742144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of serum mRNA in patients with head and neck squamous cell carcinoma at whole-genome scale.
    Čapková M; Šáchová J; Strnad H; Kolář M; Hroudová M; Chovanec M; Čada Z; Šteffl M; Valach J; Kastner J; Vlček Č; Smetana K; Plzák J
    Biomed Res Int; 2014; 2014():408683. PubMed ID: 24864240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities in mRNA expression of peripheral blood drug metabolizing enzymes and cancer marker genes with biopsy samples of head and neck cancer patients.
    Hasan F; Katiyar T; Maurya SS; Yadav V; Yadav S; Pandey R; Mehrotra D; Hadi R; Singh S; Bhatt ML; Parmar D
    Biomarkers; 2019 Sep; 24(6):574-583. PubMed ID: 31002268
    [No Abstract]   [Full Text] [Related]  

  • 14. MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.
    Ardalan Khales S; Ebrahimi E; Jahanzad E; Ardalan Khales S; Forghanifard MM
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e434-e441. PubMed ID: 29333702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.
    Hanemaaijer SH; van Gijn SE; Oosting SF; Plaat BEC; Moek KL; Schuuring EM; van der Laan BFAM; Roodenburg JLN; van Vugt MATM; van der Vegt B; Fehrmann RSN
    Oral Oncol; 2018 May; 80():33-39. PubMed ID: 29706186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
    Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
    Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum lactate dehydrogenase as a prognostic factor in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    Lee WH; Takenaka Y; Hosokawa K; Eguchi H; Suzuki M; Fukusumi T; Suzuki M; Inohara H
    Acta Otolaryngol; 2024; 144(5-6):398-403. PubMed ID: 39126295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the response of human head and neck squamous cell carcinoma to irradiation in a microfluidic model allowing customized therapy.
    Cheah R; Srivastava R; Stafford ND; Beavis AW; Green V; Greenman J
    Int J Oncol; 2017 Oct; 51(4):1227-1238. PubMed ID: 28902347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.